Compile Data Set for Download or QSAR
Found 96 of ic50 for UniProtKB: P11169
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50152749(CHEMBL3781913)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155671(CHEMBL3780239)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM453246(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)copy SMILEScopy InChI
Affinity DataIC50: 12nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM453265(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)copy SMILEScopy InChI
Affinity DataIC50: 26nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM453264(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)copy SMILEScopy InChI
Affinity DataIC50: 33nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155656(CHEMBL3781331)copy SMILEScopy InChI
Affinity DataIC50: 37nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155673(CHEMBL3780972)copy SMILEScopy InChI
Affinity DataIC50: 40nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50152824(CHEMBL3781548)copy SMILEScopy InChI
Affinity DataIC50: 40nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155746(CHEMBL3781151)copy SMILEScopy InChI
Affinity DataIC50: 46nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM453228(US10729691, Example 13)copy SMILEScopy InChI
Affinity DataIC50: 47nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155670(CHEMBL3780144)copy SMILEScopy InChI
Affinity DataIC50: 50nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50538375(CHEMBL4633651)copy SMILEScopy InChI
Affinity DataIC50: 58nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155715(CHEMBL3781149)copy SMILEScopy InChI
Affinity DataIC50: 60nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155585(CHEMBL3780372)copy SMILEScopy InChI
Affinity DataIC50: 60nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50152776(CHEMBL3780785)copy SMILEScopy InChI
Affinity DataIC50: 64nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM453227(US10729691, Example 12)copy SMILEScopy InChI
Affinity DataIC50: 68nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155680(CHEMBL3780717)copy SMILEScopy InChI
Affinity DataIC50: 69nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155583(CHEMBL3781835)copy SMILEScopy InChI
Affinity DataIC50: 70nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155751(CHEMBL3780460)copy SMILEScopy InChI
Affinity DataIC50: 90nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155745(CHEMBL3780043)copy SMILEScopy InChI
Affinity DataIC50: 96nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM453217(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)copy SMILEScopy InChI
Affinity DataIC50: 97nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50152825(CHEMBL3780235)copy SMILEScopy InChI
Affinity DataIC50: 110nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50152827(CHEMBL3781741)copy SMILEScopy InChI
Affinity DataIC50: 120nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155752(CHEMBL3780527)copy SMILEScopy InChI
Affinity DataIC50: 120nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50152743(CHEMBL3781308)copy SMILEScopy InChI
Affinity DataIC50: 120nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50538374(CHEMBL4637134)copy SMILEScopy InChI
Affinity DataIC50: 121nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50538373(CHEMBL4635564)copy SMILEScopy InChI
Affinity DataIC50: 138nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50538389(CHEMBL4634012)copy SMILEScopy InChI
Affinity DataIC50: 155nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM453248(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)copy SMILEScopy InChI
Affinity DataIC50: 160nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155672(CHEMBL3781183)copy SMILEScopy InChI
Affinity DataIC50: 170nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155679(CHEMBL3780772)copy SMILEScopy InChI
Affinity DataIC50: 170nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155749(CHEMBL3781625)copy SMILEScopy InChI
Affinity DataIC50: 170nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50538390(CHEMBL4638542)copy SMILEScopy InChI
Affinity DataIC50: 175nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50538386(CHEMBL4647401)copy SMILEScopy InChI
Affinity DataIC50: 179nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155747(CHEMBL3781194)copy SMILEScopy InChI
Affinity DataIC50: 200nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50538383(CHEMBL4645036)copy SMILEScopy InChI
Affinity DataIC50: 211nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50538382(CHEMBL4649311)copy SMILEScopy InChI
Affinity DataIC50: 232nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM453219(US10729691, Example 4)copy SMILEScopy InChI
Affinity DataIC50: 238nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50538387(CHEMBL4642809)copy SMILEScopy InChI
Affinity DataIC50: 238nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155714(CHEMBL3781157)copy SMILEScopy InChI
Affinity DataIC50: 250nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50152826(CHEMBL3781347)copy SMILEScopy InChI
Affinity DataIC50: 250nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50538391(CHEMBL4642046)copy SMILEScopy InChI
Affinity DataIC50: 275nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50538385(CHEMBL4632395)copy SMILEScopy InChI
Affinity DataIC50: 287nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50538365(CHEMBL4632920)copy SMILEScopy InChI
Affinity DataIC50: 298nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155753(CHEMBL3780470)copy SMILEScopy InChI
Affinity DataIC50: 320nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155681(CHEMBL3781827)copy SMILEScopy InChI
Affinity DataIC50: 320nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50538368(CHEMBL4649877)copy SMILEScopy InChI
Affinity DataIC50: 325nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155750(CHEMBL3780595)copy SMILEScopy InChI
Affinity DataIC50: 340nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50155677(CHEMBL3780765)copy SMILEScopy InChI
Affinity DataIC50: 350nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2639RM3PubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma AG

Curated by ChEMBL
LigandPNGBDBM50538372(CHEMBL4637262)copy SMILEScopy InChI
Affinity DataIC50: 365nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9NGPPubMed
Displayed 1 to 50 (of 96 total ) | Next | Last >>
Jump to: